Position in PLRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$194,260
+$43,869 QoQ
Shares Held
154,176
+25.1% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. PLRX ranks #325 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in PLRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,260 | 154,176 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $150,391 | 123,273 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $202,018 | 136,500 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $191,909 | 165,440 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $687,257 | 509,081 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,317,251 | 555,600 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $5,627,598 | 502,016 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,129,522 | 477,165 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $7,379,804 | 495,289 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,151,452 | 505,326 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,755,935 | 504,956 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,893,131 | 490,791 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,757,541 | 103,667 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,572,919 | 81,372 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,176,127 | 56,301 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $302,465 | 37,761 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,497,818 | 213,669 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,084,087 | 228,451 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,794,960 | 224,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,293,470 | 216,122 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,734,876 | 222,092 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,761,295 | 121,536 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,745,496 | 121,214 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||